Log in to save to my catalogue

NRAS -mutant melanoma: current challenges and future prospect

NRAS -mutant melanoma: current challenges and future prospect

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5558581

NRAS -mutant melanoma: current challenges and future prospect

About this item

Full title

NRAS -mutant melanoma: current challenges and future prospect

Publisher

New Zealand: Dove Medical Press Limited

Journal title

OncoTargets and therapy, 2017-01, Vol.10, p.3941-3947

Language

English

Formats

Publication information

Publisher

New Zealand: Dove Medical Press Limited

More information

Scope and Contents

Contents

Melanoma is one of the most common cutaneous cancers worldwide. Activating mutations in
oncogenes are found in a third of all human cancers and
mutations are found in 15%-20% of melanomas. The
-mutant subset of melanoma is more aggressive and associated with poorer outcomes, compared to non-
-mutant melanoma. Although immune checkpoint...

Alternative Titles

Full title

NRAS -mutant melanoma: current challenges and future prospect

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5558581

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5558581

Other Identifiers

ISSN

1178-6930

E-ISSN

1178-6930

DOI

10.2147/OTT.S117121

How to access this item